Baseline demographics of the co-therapy group appeared similar to the primary therapy group (see Additional file 1 : Table S3), and baseline disease measures showed a trend of increased severity in the co-therapy group (see Additional file 1 : Table S4).
← all excerpts
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
1
—
—